|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/00 | |
| C12N 9/24 | |||
| C12N 9/88 | |||
| C12N 9/96 |
| (11) | Number of the document | 1750757 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05749189.6 |
| Date of filing the European patent application | 2005-05-18 | |
| (97) | Date of publication of the European application | 2007-02-14 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/017464 |
| Date | 2005-05-18 |
| (87) | Number | WO 2005/112986 |
| Date | 2005-12-01 |
| (30) | Number | Date | Country code |
| 572030 P | 2004-05-18 | US | |
| 621882 P | 2004-10-25 | US |
| (72) |
CAGGIANO, Anthony, O., US
GRUSKIN, Elliott, A., US
SHEPTOVITSKY, Yelena, G., US
KASPERBAUER, Sarah, US
|
| (73) |
Acorda Therapeutics, Inc.,
420 Saw Mill River Road, Ardsley, NY 10502,
US
|
| (54) | METHODS OF PURIFYING CHONDROITINASE AND STABLE FORMULATIONS THEREOF |
| METHODS OF PURIFYING CHONDROITINASE AND STABLE FORMULATIONS THEREOF |